Fig. 3

FLT3 correlation with the formation of tertiary lymphoid structures (TLSs) in solid cancers. (A) Eight biomarkers that represent the TLSs exhibited no significant differences among a variety of cancers using the GEPIA2 database. (B) The characteristics of immune cell infiltration in AML. Three selected solid cancers were compared and the differences in immune cell infiltration were found using the TIMER database. (C) Eight biomarkers that represent the TLSs exhibited a positive correlation with the expression of FLT3 in most solid cancers using the GEPIA2 database.